$CPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATALYST PHARMACEUTICALS, INC.. Get notifications about new insider transactions in CATALYST PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 3.12 | 25,000 | 78,000 | 190,000 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 3.12 | 25,000 | 78,000 | 165,000 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 3.12 | 25,000 | 78,000 | 422,500 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 3.12 | 25,000 | 78,000 | 397,500 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 3.12 | 25,000 | 78,000 | 372,500 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 3.12 | 25,000 | 78,000 | 296,250 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 3.12 | 25,000 | 78,000 | 271,250 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 3.12 | 61,667 | 192,401 | 710,000 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 3.12 | 61,667 | 192,401 | 648,333 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 3.12 | 61,666 | 192,398 | 586,666 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 3.12 | 153,334 | 478,402 | 1,381,054 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 3.12 | 153,333 | 478,399 | 1,227,720 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 3.12 | 153,333 | 478,399 | 1,074,387 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 3.12 | 25,000 | 78,000 | 669,804 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 3.12 | 25,000 | 78,000 | 644,804 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 3.12 | 56,667 | 176,801 | 590,000 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 3.12 | 56,667 | 176,801 | 533,333 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 3.12 | 56,666 | 176,798 | 476,666 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 3.12 | 25,000 | 78,000 | 180,000 | |
Sep 02 2014 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 3.12 | 25,000 | 78,000 | 155,000 | |
Jun 04 2014 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Buy | P | 2.17 | 100,000 | 216,990 | 214,754 | 114.8 K to 214.8 K (+87.14 %) |
May 21 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.89 | 25,000 | 47,225 | 3,656,247 | 3.6 M to 3.7 M (+0.69 %) |
May 21 2014 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 1.83 | 10,000 | 18,291 | 192,126 | 182.1 K to 192.1 K (+5.49 %) |
Apr 17 2014 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.02 | 5,000 | 10,100 | 182,126 | 177.1 K to 182.1 K (+2.82 %) |
Feb 07 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.82 | 25,000 | 45,500 | 3,631,247 | 3.6 M to 3.6 M (+0.69 %) |
Feb 06 2014 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 1.81 | 10,000 | 18,099 | 177,126 | 167.1 K to 177.1 K (+5.98 %) |
Oct 25 2013 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Buy | P | 2.03 | 8,000 | 16,240 | 213,401 | 205.4 K to 213.4 K (+3.89 %) |
Oct 21 2013 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.59 | 50,000 | 79,730 | 3,606,247 | 3.6 M to 3.6 M (+1.41 %) |
Oct 21 2013 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 1.84 | 10,000 | 18,392 | 167,126 | 157.1 K to 167.1 K (+6.36 %) |
Feb 20 2013 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.46 | 50,000 | 23,000 | 3,556,247 | 3.5 M to 3.6 M (+1.43 %) |
Dec 18 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.45 | 100,000 | 44,500 | 3,449,997 | 3.3 M to 3.4 M (+2.99 %) |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 0.47 | 25,000 | 11,750 | 362,500 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 0.47 | 25,000 | 11,750 | 337,500 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 0.47 | 25,000 | 11,750 | 312,500 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 0.47 | 50,000 | 23,500 | 509,804 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Option Exercise | A | 0.47 | 50,000 | 23,500 | 286,000 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 0.47 | 50,000 | 23,500 | 161,000 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 0.47 | 50,000 | 23,500 | 261,250 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 0.47 | 66,667 | 31,333 | 540,000 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 0.47 | 66,667 | 31,333 | 473,333 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 0.47 | 66,666 | 31,333 | 406,666 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.47 | 66,667 | 31,333 | 936,054 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.47 | 66,667 | 31,333 | 869,387 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.47 | 66,666 | 31,333 | 802,720 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 0.47 | 66,667 | 31,333 | 435,000 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 0.47 | 66,667 | 31,333 | 368,333 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 0.47 | 66,666 | 31,333 | 301,666 | |
Dec 14 2012 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 0.47 | 50,000 | 23,500 | 145,000 | |
Dec 12 2012 | CPRX | CATALYST PHARMACEU ... | BIOMARIN PHARMACEUTICAL INC | 10% Owner | Option Exercise | J | 0.75 | 5,000,000 | 3,750,000 | 0 | |
Dec 12 2012 | CPRX | CATALYST PHARMACEU ... | BIOMARIN PHARMACEUTICAL INC | 10% Owner | Buy | P | 0.75 | 5,000,000 | 3,750,000 | 6,666,667 | 1.7 M to 6.7 M (+300.00 %) |
Nov 19 2012 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 0.41 | 24,000 | 9,857 | 24,000 | 0 to 24 K |
Nov 15 2012 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 0.42 | 25,000 | 10,475 | 157,126 | 132.1 K to 157.1 K (+18.92 %) |
Nov 15 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.42 | 100,000 | 42,010 | 3,349,997 | 3.2 M to 3.3 M (+3.08 %) |
Jul 05 2012 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Buy | P | 0.55 | 27,700 | 15,235 | 114,754 | 87.1 K to 114.8 K (+31.82 %) |
Jul 05 2012 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Buy | P | 0.55 | 12,300 | 6,716 | 87,054 | 74.8 K to 87.1 K (+16.45 %) |
Jul 05 2012 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Buy | P | 0.55 | 18,000 | 9,900 | 66,346 | 48.3 K to 66.3 K (+37.23 %) |
Jul 05 2012 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Buy | P | 0.54 | 2,000 | 1,080 | 48,346 | 46.3 K to 48.3 K (+4.32 %) |
Jul 03 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.54 | 700 | 375 | 3,249,997 | 3.2 M to 3.2 M (+0.02 %) |
Jul 03 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.54 | 30,500 | 16,418 | 3,249,297 | 3.2 M to 3.2 M (+0.95 %) |
May 31 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.58 | 10,000 | 5,790 | 3,218,797 | 3.2 M to 3.2 M (+0.31 %) |
Jun 01 2012 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 0.57 | 20,000 | 11,400 | 132,126 | 112.1 K to 132.1 K (+17.84 %) |
May 31 2012 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Buy | P | 0.57 | 17,300 | 9,861 | 46,346 | 29 K to 46.3 K (+59.56 %) |
May 31 2012 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 0.57 | 11,100 | 6,327 | 539,184 | 528.1 K to 539.2 K (+2.10 %) |
May 31 2012 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Buy | P | 0.58 | 20,000 | 11,696 | 205,401 | 185.4 K to 205.4 K (+10.79 %) |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | P | 1.04 | 12,500 | 13,000 | 287,500 | |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Buy | P | 0.80 | 12,500 | 10,000 | 17,294 | 4.8 K to 17.3 K (+260.74 %) |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Option Exercise | P | 1.04 | 125,000 | 130,000 | 229,000 | |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 0.80 | 125,000 | 100,000 | 528,084 | 403.1 K to 528.1 K (+31.01 %) |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | P | 1.04 | 31,250 | 32,500 | 211,250 | |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 0.80 | 31,250 | 25,000 | 112,126 | 80.9 K to 112.1 K (+38.64 %) |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | P | 1.04 | 31,250 | 32,500 | 1,009,191 | |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.80 | 31,250 | 25,000 | 3,208,797 | 3.2 M to 3.2 M (+0.98 %) |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | P | 1.04 | 125,000 | 130,000 | 125,000 | |
May 29 2012 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Buy | P | 0.80 | 125,000 | 100,000 | 1,304,134 | 1.2 M to 1.3 M (+10.60 %) |
Feb 14 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.15 | 23,400 | 26,910 | 3,202,547 | 3.2 M to 3.2 M (+0.74 %) |
Feb 14 2012 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.10 | 1,600 | 1,760 | 3,179,147 | 3.2 M to 3.2 M (+0.05 %) |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 1.07 | 25,000 | 26,750 | 275,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 1.07 | 25,000 | 26,750 | 250,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 1.07 | 25,000 | 26,750 | 225,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Option Exercise | A | 1.07 | 30,000 | 32,100 | 111,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 1.07 | 30,000 | 32,100 | 111,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 1.07 | 30,000 | 32,100 | 180,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 1.07 | 30,000 | 32,100 | 340,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 1.07 | 30,000 | 32,100 | 310,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 1.07 | 30,000 | 32,100 | 280,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 1.07 | 33,334 | 35,667 | 1,069,608 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 1.07 | 33,333 | 35,666 | 1,036,274 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 1.07 | 33,333 | 35,666 | 1,002,941 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 1.07 | 25,000 | 26,750 | 824,608 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 1.07 | 30,000 | 32,100 | 235,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 1.07 | 30,000 | 32,100 | 205,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 1.07 | 30,000 | 32,100 | 175,000 | |
Dec 19 2011 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 1.07 | 25,000 | 26,750 | 95,000 | |
Dec 14 2011 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.06 | 9,500 | 10,070 | 3,177,547 | 3.2 M to 3.2 M (+0.30 %) |
Dec 14 2011 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.06 | 500 | 528 | 3,168,047 | 3.2 M to 3.2 M (+0.02 %) |
Sep 07 2011 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Sell | S | 1.25 | 216,546 | 270,683 | 87,636 | 304.2 K to 87.6 K (-71.19 %) |
Dec 21 2010 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 0.96 | 500 | 480 | 14,493 | 14 K to 14.5 K (+3.57 %) |
Dec 21 2010 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Buy | P | 0.95 | 2,000 | 1,898 | 13,993 | 12 K to 14 K (+16.68 %) |
Nov 10 2010 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 1.09 | 30,000 | 32,700 | 81,000 | |
Nov 10 2010 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 1.09 | 25,000 | 27,250 | 799,608 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 1.09 | 20,000 | 21,800 | 200,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 1.09 | 20,000 | 21,800 | 180,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | A | 1.09 | 20,000 | 21,800 | 160,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 1.09 | 13,334 | 14,534 | 145,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 1.09 | 13,333 | 14,533 | 131,666 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Accounting Of ... | Option Exercise | A | 1.09 | 13,333 | 14,533 | 118,333 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | A | 1.09 | 20,000 | 21,800 | 200,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | A | 1.09 | 20,000 | 21,800 | 180,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | A | 1.09 | 20,000 | 21,800 | 160,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Option Exercise | A | 1.09 | 30,000 | 32,700 | 81,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 1.09 | 30,000 | 32,700 | 150,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | Miller Steve | VP Development & Ma ... | Option Exercise | A | 1.09 | 20,000 | 21,800 | 250,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | Miller Steve | VP Development & Ma ... | Option Exercise | A | 1.09 | 20,000 | 21,800 | 230,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | Miller Steve | VP Development & Ma ... | Option Exercise | A | 1.09 | 20,000 | 21,800 | 210,000 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 1.09 | 25,000 | 27,250 | 969,608 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 1.09 | 25,000 | 27,250 | 944,608 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 1.09 | 25,000 | 27,250 | 919,608 | |
Nov 09 2010 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 1.09 | 25,000 | 27,250 | 70,000 | |
Jul 08 2010 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.93 | 5,200 | 4,836 | 3,131,381 | 3.1 M to 3.1 M (+0.17 %) |
Jul 08 2010 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.92 | 500 | 460 | 3,126,181 | 3.1 M to 3.1 M (+0.02 %) |
Jul 08 2010 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.90 | 51 | 46 | 3,125,681 | 3.1 M to 3.1 M (0.00 %) |
Jul 08 2010 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.92 | 200 | 184 | 3,125,630 | 3.1 M to 3.1 M (+0.01 %) |
Jun 30 2010 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 1.05 | 2,000 | 2,099 | 80,876 | 78.9 K to 80.9 K (+2.54 %) |
Jun 28 2010 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 1.04 | 5,000 | 5,200 | 304,182 | 299.2 K to 304.2 K (+1.67 %) |
Jun 16 2010 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 1.04 | 9,359 | 9,733 | 3,125,430 | 3.1 M to 3.1 M (+0.30 %) |
Mar 18 2010 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 0.72 | 5,000 | 3,605 | 78,876 | 73.9 K to 78.9 K (+6.77 %) |
Mar 05 2010 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 0.69 | 22,500 | 15,525 | 373,900 | 351.4 K to 373.9 K (+6.40 %) |
Mar 05 2010 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 0.67 | 1,400 | 938 | 351,400 | 350 K to 351.4 K (+0.40 %) |
Mar 02 2010 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 0.67 | 5,550 | 3,719 | 296,732 | 291.2 K to 296.7 K (+1.91 %) |
Nov 20 2009 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Controller & CAO | Buy | P | 0.65 | 4,200 | 2,730 | 24,046 | 19.8 K to 24 K (+21.16 %) |
Nov 20 2009 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Controller & CAO | Buy | P | 0.65 | 5,000 | 3,250 | 19,846 | 14.8 K to 19.8 K (+33.68 %) |
Nov 19 2009 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 0.68 | 25,054 | 17,037 | 350,000 | 324.9 K to 350 K (+7.71 %) |
Nov 19 2009 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Buy | P | 0.73 | 19,846 | 14,488 | 324,946 | 305.1 K to 324.9 K (+6.50 %) |
Nov 18 2009 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 0.73 | 10,000 | 7,300 | 291,182 | 281.2 K to 291.2 K (+3.56 %) |
Nov 18 2009 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 0.73 | 10,000 | 7,300 | 73,876 | 63.9 K to 73.9 K (+15.66 %) |
Nov 16 2009 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 0.76 | 5,000 | 3,800 | 281,182 | 276.2 K to 281.2 K (+1.81 %) |
Nov 16 2009 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 0.75 | 5,000 | 3,750 | 276,182 | 271.2 K to 276.2 K (+1.84 %) |
Nov 16 2009 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 0.79 | 10,000 | 7,900 | 271,182 | 261.2 K to 271.2 K (+3.83 %) |
Nov 16 2009 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.75 | 25,000 | 18,750 | 3,116,071 | 3.1 M to 3.1 M (+0.81 %) |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | A | 0.90 | 41,667 | 37,500 | 431,842 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | A | 0.90 | 41,667 | 37,500 | 390,175 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | A | 0.90 | 41,666 | 37,499 | 348,508 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Weinstein Jack | V.P., Treasurer & C ... | Option Exercise | H | 2.98 | 145,922 | 434,848 | 306,842 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | V.P. of Regulatory ... | Option Exercise | A | 0.90 | 41,667 | 37,500 | 140,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | V.P. of Regulatory ... | Option Exercise | A | 0.90 | 41,667 | 37,500 | 98,333 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | V.P. of Regulatory ... | Option Exercise | A | 0.90 | 41,666 | 37,499 | 56,666 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | V.P. of Regulatory ... | Option Exercise | H | 2.98 | 145,922 | 434,848 | 15,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | WALLACE MILTON J | Director | Option Exercise | A | 0.90 | 30,000 | 27,000 | 51,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 0.90 | 30,000 | 27,000 | 51,000 | |
Oct 22 2009 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 0.90 | 25,000 | 22,500 | 120,000 |